研究胰岛素在调节生长板发育中的局部芳酶中的作用
Sicui Hu1,2, MinMin Xue3, Yao Dong4
1Department of Pediatrics, General Hospital of Tianjin Medical University, Tianjin, China.
PloS one
|December 2, 2025
概括
在大鼠中,肥胖引起的高胰岛素血症通过上调胰岛素受体和芳酶表达来增加生长板的长度,这表明胰岛素信号与骨生长之间存在联系. 需要进一步的研究来澄清这些分子机制.
科学领域:
- 内分泌学和新陈代谢学
- 骨生物学和生理学 骨生物学和生理学
- 发展生物学 发展生物学
背景情况:
- 怀疑与肥胖相关的高胰岛素血症会对线性生长产生负面影响,但根本机制尚未完全理解.
- 这项研究利用Sprague-Dawley大鼠的高脂肪饮食诱导的肥胖模型来研究这些对生长的影响.
研究的目的:
- 研究肥胖相关高胰岛素血症影响线性生长的机制.
- 为了检查胰岛素信号和芳香酶表达在肥胖大鼠模型中桃体生长板发育中的作用.
主要方法:
- 在Sprague-Dawley大鼠中进行高脂肪饮食,以诱导肥胖,持续6周.
- 测量了体重,鼻长度和血清胰岛素水平.
- 在收获的骨头上进行了生长板的长度,组织学分析,免疫组织化学和分子分析 (PCR,西式涂抹).
主要成果:
- 与对照组相比,肥胖大鼠的血清胰岛素水平显著上升,生长板长度增加,增强的增殖/增高区域.
- 在肥胖大鼠的生长板中观察到增加的芳酶 (CYP19A1) 和胰岛素受体 (IR) 表达和活性.
- 在肥胖大鼠中,免疫组织化学局部化了芳酶和IR,主要是到生长板的过度缩区域.
结论:
- 在老鼠中,肥胖引起的高胰岛素血症与体生长板的长度增加有关.
- 胰岛素信号似乎调节了芳香酶的表达,影响了生长板的发育.
- 精确的分子通路将胰岛素受体信号与芳酶调节联系起来,需要进一步阐明.
相关概念视频
01:28Insulin: The Receptor and Signaling Pathways
2.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.7K
01:17Hormones and Bone Tissue
3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
01:16Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K
01:19Regulation of Metabolism
11.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.4K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
01:16Insulin: Dosing Regimen and Adverse Effects
658
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
658